Is AI/ML Bringing Medicines To Patients Faster And Cheaper?

By Hettie Stroebel

Mathematician Alan Turing changed history in 1950 with a simple question: “Can machines think?”

The phrase artificial intelligence (AI) was coined in 1956, yet the pharmaceutical industry embraced artificial intelligence and machine learning (ML) only about 15 to 20 years ago as a technology for use in drug discovery and drug development. It is critical to move beyond simply using AI as a buzzword and instead determine if AI/ML does indeed change the discovery and clinical development process by bringing innovation to patients faster and at a lower investment.